CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Treatment of chronic Hepatitis C Genotype 1 (G1) infection with Boceprevir (BOC) in German Real-Life: Impact of Hemoglobin (Hb) decline on virologic response
DOI 10.1055/s-0034-1386295
Bibliografische Angaben
Nachweis in CareLit
Autor:innenG Teuber, P Buggisch, H Löhr, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthoeft, A Herrmann, M Hoesl, U Naumann, T Dahhan, D Hartmann, B Dreher, M Bilzer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Data regarding the severity and impact of hemoglobin (Hb) decline caused by triple therapy with boceprevir (BOC) in real-life are still scarce and were evaluated in the present interim analysis of the German NOVUS observational study. Methods: From April 2012 until November 2013, 469 patients with G1 infection were recruited in the ongoing NOVUS study by 97 practices and hospitals in Germany. Patients we…
Zitieren
Zitierempfehlung
G Teuber, P Buggisch, H Löhr, H Steffens, M Kraus, C John, P Geyer, B Weber, T Witthoeft, A Herrmann, M Hoesl, U Naumann, T Dahhan, D Hartmann, B Dreher, M Bilzer (2014) Treatment of chronic Hepatitis C Genotype 1 (G1) infection with Boceprevir (BOC) in German Real-Life: Impact of Hemoglobin (Hb) decline on virologic response. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0034-1386295
Mit CareLit weiterarbeiten